As of 2026-03-16, the Relative Valuation of Rhythm Pharmaceuticals Inc (RYTM) is (65.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 87.38 USD, the upside of Rhythm Pharmaceuticals Inc based on Relative Valuation is -175.2%.
The range of the Relative Valuation is (56.58) - (73.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 27.4x | 23.4x |
| Forward P/E multiples | 19.3x - 25.4x | 22.3x |
| Fair Price | (56.58) - (73.22) | (65.69) |
| Upside | -164.8% - -183.8% | -175.2% |
| Date | P/E |
| 2026-03-13 | -30.36 |
| 2026-03-12 | -31.67 |
| 2026-03-11 | -31.28 |
| 2026-03-10 | -32.32 |
| 2026-03-09 | -32.31 |
| 2026-03-06 | -32.49 |
| 2026-03-05 | -31.78 |
| 2026-03-04 | -31.62 |
| 2026-03-03 | -31.12 |
| 2026-03-02 | -32.99 |
| 2026-02-27 | -32.22 |
| 2026-02-26 | -34.08 |
| 2026-02-25 | -34.45 |
| 2026-02-24 | -34.28 |
| 2026-02-23 | -33.48 |
| 2026-02-20 | -34.67 |
| 2026-02-19 | -35.84 |
| 2026-02-18 | -35.20 |
| 2026-02-17 | -35.63 |
| 2026-02-13 | -34.08 |
| 2026-02-12 | -33.38 |
| 2026-02-11 | -34.21 |
| 2026-02-10 | -35.74 |
| 2026-02-09 | -36.13 |
| 2026-02-06 | -36.00 |
| 2026-02-05 | -36.09 |
| 2026-02-04 | -37.52 |
| 2026-02-03 | -37.63 |
| 2026-02-02 | -37.87 |
| 2026-01-30 | -35.62 |
| 2026-01-29 | -36.03 |
| 2026-01-28 | -35.67 |
| 2026-01-27 | -36.67 |
| 2026-01-26 | -35.92 |
| 2026-01-23 | -35.74 |
| 2026-01-22 | -37.65 |
| 2026-01-21 | -36.81 |
| 2026-01-20 | -35.65 |
| 2026-01-16 | -35.31 |
| 2026-01-15 | -36.85 |
| 2026-01-14 | -39.38 |
| 2026-01-13 | -37.46 |
| 2026-01-12 | -36.45 |
| 2026-01-09 | -35.10 |
| 2026-01-08 | -33.86 |
| 2026-01-07 | -35.30 |
| 2026-01-06 | -34.54 |
| 2026-01-05 | -35.39 |
| 2026-01-02 | -36.49 |
| 2025-12-31 | -37.19 |